Literature DB >> 2015619

Calcium inhibition of cardiac adenylyl cyclase. Evidence for two distinct sites of inhibition.

R A Colvin1, J A Oibo, R A Allen.   

Abstract

Increasing the free calcium concentration from 10(-8) M to 10(-4) M inhibited cardiac sarcolemmal adenylyl cyclase activated by the addition of 5 X 10(-4) M forskolin or 1 X 10(-4) M GTP or Gpp(NH)p. The calcium inhibition curve in the presence of all three activators was shallow and best fit by a two site model of high affinity (less than 1.0 microM) and low affinity (greater than 0.1 mM). Gpp(NH)p appeared to decrease the sensitivity of adenylyl cyclase to inhibition by calcium at the high affinity site. Similar inhibition constants were obtained with each of the activators. Calmodulin content of native freeze-thaw vesicles was 76.2 +/- 14.2 ng/mg. Treatment of the vesicles with 1 mM EGTA to remove calmodulin significantly reduced calmodulin content to 19.7 +/- 1.35 ng/mg. This treatment had no significant effect on the calcium inhibition profile. Increasing free calcium to 3 X 10(-6) M was shown to have no effect on the EC50 estimated for either Gpp(NH)p or forskolin but did slightly increase the EC50 estimated for Mg2+ in the presence of maximal concentrations of either activator. Nevertheless, maximally stimulating concentrations of Mg2+ were unable to overcome calcium inhibition. Pretreatment of sarcolemmal membranes with pertussis toxin was shown to have no significant effect on calcium inhibition of adenylyl cyclase. The results suggest that the overall inhibitory action of calcium was most likely calmodulin independent and involved a direct interaction with the catalytic subunit at two distinct sites of high and low affinity. At the low affinity site calcium most likely competes with Mg2+ for an allosteric divalent cation binding site.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015619     DOI: 10.1016/0143-4160(91)90081-o

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  17 in total

1.  Alterations of cardiac beta-adrenoceptor mechanisms due to calcium depletion and repletion.

Authors:  Xi Wang; Jingwei Wang; Satoshi Takeda; Vijayan Elimban; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

2.  Ca(2+)-stimulated adenylyl cyclases regulate the L-type Ca(2+) current in guinea-pig atrial myocytes.

Authors:  Thomas P Collins; Derek A Terrar
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

3.  Inhibition of adenylate cyclase by Ca(2+)--a counterpart to stimulation by Ca2+/calmodulin.

Authors:  D M Cooper
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

Review 4.  Regulation and organization of adenylyl cyclases and cAMP.

Authors:  Dermot M F Cooper
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

5.  Predominant expression of type-VI adenylate cyclase in C6-2B rat glioma cells may account for inhibition of cyclic AMP accumulation by calcium.

Authors:  M A Debernardi; R Munshi; M Yoshimura; D M Cooper; G Brooker
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

6.  Ca(2+)-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function.

Authors:  T Stevens; Y Nakahashi; D N Cornfield; I F McMurtry; D M Cooper; D M Rodman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Single cell Ca2+/cAMP cross-talk monitored by simultaneous Ca2+/cAMP fluorescence ratio imaging.

Authors:  M A DeBernardi; G Brooker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells.

Authors:  M Yoshimura; D M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Digoxin reduces beta-adrenergic contractile response in rabbit hearts. Ca(2+)-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange.

Authors:  K Nagai; T Murakami; T Iwase; T Tomita; S Sasayama
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

10.  Ca(2+)-dependent and -independent mechanism of cyclic-AMP reduction: mediation by bradykinin B2 receptors.

Authors:  H Sipma; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.